Optimum Client’s Win Big at LSX European Lifestars Awards! Congratulations to Optimum’s clients – Asceneuron SA, Calliditas Therapeutics, DISCO Pharmaceuticals GmbH, Sofinnova Partners portfolio company Moon Surgical, Myricx Bio, and Novo Holdings, all of whom took home LSX European Lifestars awards! Plus, a special moment for Optimum’s Zoe Bolt who presented the award for Private […]
Just days after anti-vaxxer Robert F Kennedy Jr was nominated as President-elect Donald Trump’s health secretary, the first case of the mpox strain of most concern to scientists has been recorded in the U.S. While mpox has been declared a global health emergency by the World Health Organization, U.S. public health officials have not seemed […]
During the BIO-Europe conference in Stockholm, Optimum co-hosted a special reception featuring a fireside chat with Renée Aguiar-Lucander, former CEO of Calliditas, who led the Swedish company since 2017 until recently – taking it from small biotech to its $1.1 billion acquisition. Here, we tell the story of her remarkable seven-year journey with the firm. Novo […]
During the BIO-Europe conference in Stockholm, Optimum co-hosted a special reception featuring a fireside chat with Renée Aguiar-Lucander, former CEO of Calliditas, who led the Swedish company since 2017 until recently – taking it from small biotech to its $1.1 billion acquisition. Here, we tell the story of her remarkable seven-year journey with the firm. […]
By Richard Staines, Optimum Strategic Communications The re-election of Donald Trump as President of the Unites States represents a seismic shift in the U.S. political system, with huge ramifications for all policy areas including healthcare. But, at the time of writing, the identity of the next Secretary of the Department of Health and Human Services […]
